Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
SALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc (MYGN). (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced that the Journal of ...
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a ...
Myriad Genetics, Inc. MYGN recently published results from a meta-analysis in the Journal of Clinical Psychopharmacology, stating the superiority of the company’s GeneSight Psychotropic test over ...
ST. PAUL, Minn., April 30 (UPI) --Fear of side effects prevents more than half of those diagnosed with treatable depression and anxiety from taking medications that could help them, according to a ...
Neuroaffiming Autism and ADHD evaluation for adults and teens (Ages 12+) and holistic medication management & genesight testing for neurodivergent folx. I take a collaborative, non-pathologizing ...
StudyFinds on MSN
Scientists built a digital ‘twin brain’ to simulate how patients might respond to psychiatric treatments
In A Nutshell Researchers in Japan built an AI system that constructs a personalized virtual brain from each individual’s ...
As a Psychiatric Nurse Practitioner, my focus is on providing compassionate, evidence-based care to individuals seeking support for their mental health. I believe in creating a safe, collaborative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results